Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / COM
-
Number of holders
-
68
-
Total 13F shares, excl. options
-
11,840,854
-
Shares change
-
-1,579,641
-
Total reported value, excl. options
-
$38,602,556
-
Value change
-
-$5,136,200
-
Put/Call ratio
-
95%
-
Number of buys
-
28
-
Number of sells
-
-37
-
Price
-
$3.26
Significant Holders of Humacyte, Inc. - COM (HUMA) as of Q3 2022
87 filings reported holding HUMA - Humacyte, Inc. - COM as of Q3 2022.
Humacyte, Inc. - COM (HUMA) has 68 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11,840,854 shares
.
Largest 10 shareholders include VANGUARD GROUP INC (2,671,123 shares), BlackRock Inc. (2,211,355 shares), York Capital Management Global Advisors, LLC (1,399,424 shares), GEODE CAPITAL MANAGEMENT, LLC (681,797 shares), UBS OCONNOR LLC (595,172 shares), Prescott General Partners LLC (568,246 shares), MILLENNIUM MANAGEMENT LLC (423,880 shares), STATE STREET CORP (418,613 shares), LPL Financial LLC (313,040 shares), and CHARLES SCHWAB INVESTMENT MANAGEMENT INC (303,724 shares).
This table shows the top 68 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.